Claude Schulman
Papers
1
Total Citations
146
H-Index
1
About
Claude Schulman is a distinguished urological surgeon and researcher whose work has significantly advanced the understanding of thromboembolic complications in prostate cancer surgery. His research focuses on the prevention and management of venous thromboembolism (VTE) in urological oncology, particularly in patients undergoing minimally invasive radical prostatectomy. Schulman’s landmark multi-institutional study, cited over 140 times, provided critical data on the incidence of symptomatic deep venous thrombosis and pulmonary embolism following laparoscopic and robot-assisted laparoscopic radical prostatectomy. This work established evidence-based benchmarks for perioperative thromboprophylaxis, directly influencing clinical guidelines and reducing surgical risks. Beyond this, Schulman has contributed extensively to the fields of benign prostatic hyperplasia, erectile dysfunction, and prostate cancer biomarkers. His impact is reflected in a career spanning decades, with numerous high-impact publications that have shaped modern urological practice. A pioneer in minimally invasive surgery, Schulman’s research continues to guide surgeons in optimizing patient safety and outcomes, making him a key figure in the evolution of urological oncology.
Research Focus
Key Achievements
Top Papers
- 1